RBC Life Sciences Inc logo

RBCL - RBC Life Sciences Inc Share Price

$0.25 0.0  0.0%

Last Trade - 20/10/20

Sector
Consumer Cyclicals
Size
Micro Cap
Market Cap £421k
Enterprise Value £-1.17m
Revenue £18.3m
Position in Universe th / 6440
Bullish
Bearish
Unlock RBCL Revenue
Momentum
Relative Strength (%)
1m +96.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -48.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2009 2010 2011 2012 2013 2014 2015E 2016E CAGR / Avg
24.9 28.2 28.4 25.2 25.5 28.3 +2.6%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2015, RBC Life Sciences Inc. revenues decreased 20% to $17M. Net loss decreased 9% to $465K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Distributor Commissions decrease of 9% to $3.2M (expense), Interest Expense decrease of 43% to $42K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RBCL Revenue Unlock RBCL Revenue

Net Income

RBCL Net Income Unlock RBCL Revenue

Normalised EPS

RBCL Normalised EPS Unlock RBCL Revenue

PE Ratio Range

RBCL PE Ratio Range Unlock RBCL Revenue

Dividend Yield Range

RBCL Dividend Yield Range Unlock RBCL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
RBCL EPS Forecasts Unlock RBCL Revenue
Profile Summary

RBC Life Sciences, Inc. is engaged in the marketing of nutritional supplements and personal care products through subsidiaries in North America and Southeast Asia and through licensees in Russia/Eastern Europe. The Company's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.

Directors
Last Annual December 31st, 2014
Last Interim September 30th, 2015
Incorporated October 4, 1999
Public Since March 27, 1996
No. of Shareholders: n/a
No. of Employees: 76
Sector Consumer Cyclicals
Industry Specialty Retailers
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 2,213,010
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RBCL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RBCL
Upcoming Events for RBCL
Frequently Asked Questions for RBC Life Sciences Inc
What is the RBC Life Sciences Inc share price?

As of 20/10/20, shares in RBC Life Sciences Inc are trading at $0.25, giving the company a market capitalisation of £421k. This share price information is delayed by 15 minutes.

How has the RBC Life Sciences Inc share price performed this year?

Shares in RBC Life Sciences Inc are currently trading at $0.25 and the price has moved by 0.166k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the RBC Life Sciences Inc price has moved by 0.144k% over the past year.

What are the analyst and broker recommendations for RBC Life Sciences Inc?

There are no analysts currently covering RBC Life Sciences Inc.

When will RBC Life Sciences Inc next release its financial results?

RBC Life Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-09-30
What is the RBC Life Sciences Inc dividend yield?

RBC Life Sciences Inc does not currently pay a dividend.

Does RBC Life Sciences Inc pay a dividend?

RBC Life Sciences Inc does not currently pay a dividend.

When does RBC Life Sciences Inc next pay dividends?

RBC Life Sciences Inc does not currently pay a dividend.

How do I buy RBC Life Sciences Inc shares?

To buy shares in RBC Life Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of RBC Life Sciences Inc?

Shares in RBC Life Sciences Inc are currently trading at $0.25, giving the company a market capitalisation of £421k.

Where are RBC Life Sciences Inc shares listed? Where are RBC Life Sciences Inc shares listed?

Here are the trading details for RBC Life Sciences Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: RBCL
What kind of share is RBC Life Sciences Inc?

We were not able to load our ranking data for RBC Life Sciences Inc

Is there a RBC Life Sciences Inc share price forecast 2020?

We were not able to load any forecast data for RBC Life Sciences Inc.

How can I tell whether the RBC Life Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RBC Life Sciences Inc. Over the past six months, the relative strength of its shares against the market has been 44.55%. At the current price of $0.25, shares in RBC Life Sciences Inc are trading at -30.1% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the RBC Life Sciences Inc PE Ratio?

We were not able to find PE ratio data for RBC Life Sciences Inc.

Who are the key directors of RBC Life Sciences Inc?

RBC Life Sciences Inc's management team is headed by:

Clinton Howard - CHM
Steven Brown - PRE
Andrew Howard - DRC
Joseph Philipp - IND
Douglas Wheeler - VOP
Cynthia Tysinger - IND
Daley Seeker - SEC
Barton Dangerfield - VPR
Who are the major shareholders of RBC Life Sciences Inc?

Here are the top five shareholders of RBC Life Sciences Inc based on the size of their shareholding:

Similar to RBCL
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.